• LAST PRICE
    2.6500
  • TODAY'S CHANGE (%)
    Trending Down-0.0400 (-1.4870%)
  • Bid / Lots
    2.0100/ 1
  • Ask / Lots
    2.6500/ 10
  • Open / Previous Close
    2.7500 / 2.6900
  • Day Range
    Low 2.6300
    High 2.7500
  • 52 Week Range
    Low 0.3599
    High 6.0400
  • Volume
    389,753
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 2.69
TimeVolumeADCT
09:32 ET151412.69
09:34 ET2002.71
09:36 ET21082.7
09:38 ET3002.72
09:39 ET51372.71
09:41 ET18402.71
09:43 ET24112.66
09:45 ET18552.655
09:48 ET5082.66
09:50 ET14022.66
09:52 ET10002.68
09:54 ET46672.7
09:56 ET43002.71
09:57 ET31962.69
09:59 ET17832.71
10:01 ET35022.7
10:03 ET36652.73
10:06 ET68942.73
10:10 ET70152.69
10:12 ET24862.65
10:14 ET43592.66
10:15 ET15482.67
10:17 ET28272.65
10:19 ET15122.65
10:21 ET24452.69
10:24 ET12002.68
10:26 ET29022.71
10:28 ET1002.7
10:30 ET27262.7
10:32 ET12462.71
10:33 ET15792.735
10:35 ET2002.74
10:39 ET14102.73
10:42 ET2042.73
10:44 ET13792.73
10:46 ET4002.725
10:48 ET29972.73
10:50 ET3012.74
10:51 ET1002.74
10:55 ET3002.7491
10:57 ET6012.74
11:00 ET11002.725
11:06 ET14712.72
11:08 ET5002.725
11:09 ET20522.705
11:11 ET16592.7
11:13 ET1002.695
11:18 ET18842.71
11:20 ET1002.715
11:24 ET25052.68
11:26 ET4002.695
11:27 ET10022.69
11:29 ET47952.7
11:31 ET9682.6927
11:36 ET19002.71
11:38 ET1002.71
11:40 ET5262.71
11:42 ET17002.695
11:45 ET1122.69
11:47 ET35132.69
11:51 ET1002.69
11:54 ET5632.7
11:56 ET16802.71
11:58 ET1002.72
12:00 ET16822.7
12:02 ET1002.69
12:03 ET2642.7
12:05 ET2002.69
12:09 ET20832.695
12:12 ET1002.695
12:14 ET2422.7
12:16 ET6002.695
12:21 ET45062.7
12:23 ET1002.7
12:25 ET9992.7
12:27 ET2002.695
12:30 ET9162.7
12:38 ET4002.71
12:39 ET1002.71
12:41 ET1002.705
12:43 ET15572.7
12:48 ET8012.69
12:50 ET2802.685
12:52 ET7082.69
12:56 ET9002.71
12:57 ET6102.715
12:59 ET25982.71
01:01 ET10882.71
01:03 ET5162.71
01:06 ET20922.72
01:08 ET11652.725
01:10 ET8372.715
01:12 ET1002.715
01:14 ET21112.725
01:17 ET2002.73
01:19 ET2002.73
01:21 ET1002.72
01:24 ET17222.71
01:26 ET4692.72
01:28 ET3002.72
01:30 ET2002.72
01:35 ET17272.71
01:37 ET1002.71
01:39 ET1002.72
01:46 ET2982.71
01:48 ET1002.715
01:50 ET3002.715
01:51 ET14042.73
01:53 ET13072.72
01:57 ET4182.71
02:00 ET1002.715
02:02 ET4242.71
02:04 ET1002.71
02:06 ET1002.71
02:08 ET39442.69
02:09 ET1702.705
02:11 ET1002.705
02:15 ET4502.7
02:18 ET22152.73
02:20 ET20422.72
02:22 ET2002.71
02:24 ET71562.71
02:26 ET21612.7
02:27 ET6282.7
02:31 ET1002.7
02:33 ET1002.695
02:38 ET5002.69
02:40 ET12522.68
02:42 ET22422.695
02:44 ET9642.69
02:45 ET4002.6901
02:47 ET4222.69
02:49 ET5032.695
02:54 ET12942.7
02:56 ET5192.71
02:58 ET17102.71
03:00 ET28482.71
03:02 ET3722.7
03:03 ET2952.695
03:05 ET5002.69
03:07 ET28762.7
03:09 ET1002.69
03:12 ET1002.695
03:14 ET10662.69
03:16 ET10002.71
03:18 ET255102.665
03:20 ET16952.665
03:21 ET24582.65
03:23 ET23802.65
03:25 ET15882.64
03:27 ET1002.64
03:30 ET27462.67
03:32 ET10462.68
03:34 ET27022.66
03:38 ET1002.65
03:39 ET8532.655
03:41 ET3772.65
03:43 ET47652.66
03:45 ET4242.665
03:48 ET1082.66
03:50 ET9082.65
03:52 ET71872.66
03:54 ET3002.66
03:56 ET77322.665
03:57 ET16882.665
03:59 ET429772.65
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesADCT
ADC Therapeutics SA
254.9M
-1.0x
---
United StatesPSTX
Poseida Therapeutics Inc
269.5M
-2.4x
---
United StatesCDXS
Codexis Inc
207.4M
-3.1x
---
United StatesENTA
Enanta Pharmaceuticals Inc
252.7M
-1.9x
---
United StatesADAP
Adaptimmune Therapeutics PLC
227.5M
-1.2x
---
United StatesMGNX
MacroGenics Inc
273.7M
-11.6x
---
As of 2024-06-22

Company Information

ADC Therapeutics SA is a Switzerland-based clinical-stage oncology drug discovery and development company. It develops antibody drug conjugates (ADCs) for the treatment of both solid and hematological cancers. It employs monoclonal antibodies specific to particular tumor antigens conjugated to a class of pyrrolobenzodiazepine (PBD)-based warheads to selectively target and kill cancer cells. The Company has multiple PBD-based ADCs in ongoing clinical trials, ranging from first in human to pivotal Phase II clinical trials, and numerous preclinical ADCs in development. Its main drug candidates are ADCT-301 for the treatment of lymphoma and leukemia and ADCT-402 for the treatment of non-Hodgkin’s lymphoma and B-cell leukemia. It serves customers in the United States, Switzerland, and the United Kingdom.

Contact Information

Headquarters
Biopole, route de la Corniche 3BEPALINGES, Switzerland 1066
Phone
---
Fax
---

Executives

Non-Executive Chairman of the Board
Ron Squarer
Chief Executive Officer, Director
Ameet Mallik
Chief Financial Officer
Jose Carmona
Chief Scientific Officer
Patrick Van Berkel
Chief Legal Officer
Peter Graham

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$254.9M
Revenue (TTM)
$68.6M
Shares Outstanding
96.2M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.57
EPS
$-2.77
Book Value
$-1.80
P/E Ratio
-1.0x
Price/Sales (TTM)
3.7
Price/Cash Flow (TTM)
---
Operating Margin
-216.68%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.